Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ImmuCell
AddedFeb 21, 2024
UpdatedJul 17, 2026
ImmuCell

ImmuCell

Public

US-based ImmuCell Corp. develops milk-derived antibody products to treat gastrointestinal infections and manufactures bovine lactoferrin.

HQ
Portland, ME, US
Founded
1987
Overview
Compare
Fundraising
Employees
Website

Founded in Portland, United States, ImmuCell Corporation is a biotechnology company dedicated to developing and manufacturing milk-derived passive antibody products aimed at preventing and treating gastrointestinal infections in both humans and animals. Their core mission is to improve animal health and productivity through innovative solutions. Key products include First Defense®, which provides immediate protection against scours in newborn calves, and bovine lactoferrin. The company also engages in joint ventures for products like Crypto-Scan, a drinking-water test marketed in the UK.

Notable figures affiliated with ImmuCell include Brad Scott from Scott Brothers Dairy, who endorses their flagship product, First Defense®. The company has achieved significant milestones, such as securing distribution agreements and expanding their product line to include essential health solutions like bovine lactoferrin. ImmuCell's impact is evident in its contribution to improving livestock health and productivity, thereby supporting the agricultural sector with effective and reliable biotechnological advancements.

ImmuCell - Similar Companies

Immunaeon logo

Immunaeon

immunaeon.com

Excelimmune logo

Excelimmune

excelimmune.com

Imunon logo

Imunon

imunon.com

ImmunityBio logo

ImmunityBio

immunitybio.com

Inimmune logo

Inimmune

inimmune.com

ImmuneID logo

ImmuneID

ImmuRx logo

ImmuRx

immurx.com

ImmunGene logo

ImmunGene

ImmunoProfile logo

ImmunoProfile

immunoprofile.com

ImmuneXcite logo

ImmuneXcite

IGM Biosciences logo

IGM Biosciences

igmbio.com

Immusoft logo

Immusoft

immusoft.com

INmune Bio logo

INmune Bio

inmunebio.com

BioClonetics Immunotherapeutics logo

BioClonetics Immunotherapeutics

Infinimmune logo

Infinimmune

infinimmune.com

ImmuCell - Quick Facts

Who are ImmuCell's competitors?

Companies similar to ImmuCell include Immunaeon, Excelimmune, Imunon and ImmunityBio.

When was ImmuCell founded?

ImmuCell was founded in 1987.

Where is ImmuCell's headquarters located?

ImmuCell's headquarters is located in Portland, ME, US.

When was ImmuCell's last funding round?

ImmuCell's most recent funding round was for $3M (USD) in June 2023.

How much has ImmuCell raised to-date?

As of Jun 15, 2023, ImmuCell has raised a total of $17.7M (USD).

How many employees does ImmuCell have?

ImmuCell has 72 employees as of Feb 6, 2024.

ImmuCell - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Antibody Products
  • Lactoferrin
Tags
  • Healthtech
Unique IDs
  • secCik: 0000811641
  • ticker: ICCC
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 25 more industry codes
NAICS
  • 310000Manufacturing
  • 311000Food Manufacturing
  • 311100Animal Food Manufacturing
  • 311110Animal Food Manufacturing
  • 311119Other Animal Food Manufacturing
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325413In-Vitro Diagnostic Substance Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2000Food And Kindred Products
  • 2040Grain Mill Products
  • 2048Prepared Feeds And Feed Ingredients For Animals And Fowls, Except Dog And Cat
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 1080Manufacture of prepared animal feeds